Savara Inc (SVRA) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Savara reported revenue of $0. Net income was -$118.8M, or -$0.53 per diluted share. Operating activities generated -$101.0M of cash, leaving -$101.0M of free cash flow. At fiscal year end, Savara held $253.4M in total assets against $50.3M in total liabilities, including $33.2M of cash and equivalents.
Open the full interactive Savara financials → Quarterly statements, key ratios, valuation history and price charts.
Savara Key Stats
| Share Price | $4.78 |
|---|---|
| Market Cap | $1.21B |
| 52-Week Range | $3.38 – $6.94 |
| Shares Outstanding | 253.6 million (basic, 2026 Q2) |
Savara Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $257,000 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$49.3M | -$41.5M | -$38.8M | -$60.0M | -$103.2M | -$123.5M |
| Pre-Tax Income | -$49.6M | -$43.0M | -$38.1M | -$54.7M | -$95.9M | -$118.8M |
| Income Tax | — | — | — | — | $9,000 | $0 |
| Net Income | -$49.6M | -$43.0M | -$38.1M | -$54.7M | -$95.9M | -$118.8M |
| Diluted EPS | -$0.84 | -$0.32 | -$0.25 | -$0.33 | -$0.48 | -$0.53 |
Savara Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$29.6M | -$32.2M | -$37.3M | -$40.2M |
| Diluted EPS | -$0.14 | -$0.14 | -$0.15 | -$0.16 |
Savara Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $22.9M | $34.0M | $52.1M | $26.6M | $15.1M | $33.2M |
| Current Assets | $85.1M | $165.0M | $129.0M | $165.9M | $202.1M | $241.6M |
| Total Assets | $97.7M | $176.6M | $139.8M | $177.6M | $212.9M | $253.4M |
| Current Liabilities | $8.2M | $14.7M | $5.9M | $10.6M | $14.7M | $20.4M |
| Total Long-Term Debt | $25.1M | $25.7M | $26.1M | $26.3M | $26.6M | $29.9M |
| Total Liabilities | $33.4M | $32.1M | $32.0M | $37.2M | $41.4M | $50.3M |
| Shareholders' Equity | $64.4M | $144.5M | $107.8M | $140.4M | $171.4M | $203.1M |
Savara Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$39.8M | -$40.1M | -$34.6M | -$51.1M | -$89.1M | -$101.0M |
| Cash From Investing | $9.1M | -$69.5M | $52.6M | -$57.1M | -$39.9M | -$18.4M |
| Cash From Financing | $3.7M | $120.8M | $87,000 | $82.8M | $117.6M | $137.8M |
| Free Cash Flow | -$39.8M | -$40.2M | -$34.6M | -$51.4M | -$89.1M | -$101.0M |
Figures from Savara's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Savara financials page for every line item.
Savara Company Profile
| Ticker | SVRA |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Austin, Texas |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001160308 |
Frequently Asked Questions
What was Savara's revenue in fiscal 2025?
Savara (SVRA) reported revenue of $0 for fiscal 2025.
What is Savara's annual revenue history?
Savara's annual revenue by fiscal year: 2020: $257,000; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Savara's net income in fiscal 2025?
Savara reported net income of -$118.8M for fiscal 2025.
What was Savara's earnings per share (EPS) in fiscal 2025?
Savara's diluted EPS was -$0.53 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Savara generate in fiscal 2025?
Savara generated -$101.0M of free cash flow in fiscal 2025.
What was Savara's revenue last quarter?
In its most recent reported quarter (2026 Q2), Savara reported revenue of $0.
How much debt does Savara have?
Savara reported $29.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Savara are outstanding?
Savara reported a weighted average of 253.6 million basic shares outstanding in 2026 Q2.
What is Savara's market cap?
Based on its latest closing price, Savara (SVRA) has a market capitalization of about $1.21B.
When does Savara's fiscal year end?
Savara's fiscal year end, as registered with the SEC, is December 31.
Where is Savara headquartered?
Savara lists its business address in Austin, Texas in its SEC filings.